MedKoo Cat#: 597097 | Name: KKI 7

Description:

WARNING: This product is for research use only, not for human or veterinary use.

KKI 7 is an analogue peptide.

Chemical Structure

KKI 7
KKI 7
CAS#113584-01-3

Theoretical Analysis

MedKoo Cat#: 597097

Name: KKI 7

CAS#: 113584-01-3

Chemical Formula: C36H58N10O8

Exact Mass: 758.4439

Molecular Weight: 758.92

Elemental Analysis: C, 56.98; H, 7.70; N, 18.46; O, 16.86

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
KKI 7; KKI-7; KKI7; N-Cyclohexylacetyl-phe-arg-ser-val-gln-NH2;
IUPAC/Chemical Name
(S)-2-((2S,5S,8S,11S)-11-benzyl-14-cyclohexyl-8-(3-guanidinopropyl)-5-(hydroxymethyl)-2-isopropyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecanamido)pentanediamide
InChi Key
CQRVUZFZOUAQCT-DJNSEWAMSA-N
InChi Code
InChI=1S/C36H58N10O8/c1-21(2)30(35(54)43-24(31(38)50)15-16-28(37)48)46-34(53)27(20-47)45-32(51)25(14-9-17-41-36(39)40)44-33(52)26(18-22-10-5-3-6-11-22)42-29(49)19-23-12-7-4-8-13-23/h3,5-6,10-11,21,23-27,30,47H,4,7-9,12-20H2,1-2H3,(H2,37,48)(H2,38,50)(H,42,49)(H,43,54)(H,44,52)(H,45,51)(H,46,53)(H4,39,40,41)/t24-,25-,26-,27-,30-/m0/s1
SMILES Code
O=C(N)CC[C@@H](C(N)=O)NC([C@H](C(C)C)NC([C@H](CO)NC([C@H](CCCNC(N)=N)NC([C@H](CC1=CC=CC=C1)NC(CC2CCCCC2)=O)=O)=O)=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 758.92 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Rebuffat P, Neri G, Bahçelioglu M, Malendowicz LK, Nussdorfer GG. Prolonged kallikrein inhibition does not affect the basal growth and secretory capacity of rat adrenal cortex, but enhances mineralo- and glucocorticoid response to ACTH and handling stress. Histol Histopathol. 2000 Apr;15(2):441-4. doi: 10.14670/HH-15.441. PubMed PMID: 10809362. 2: Burton J, Benetos A. The design of specific inhibitors of tissue kallikrein and their effect on the blood pressure of the rat. Adv Exp Med Biol. 1989;247B:9-13. PubMed PMID: 2610106. 3: Okunishi H, Spragg J, Burton J, Toda N. In vivo inhibition of tissue kallikreins by kininogen sequence analogue peptides. Adv Exp Med Biol. 1989;247B:23-8. PubMed PMID: 2481944. 4: Okunishi H, Spragg J, Burton J. In vivo assay of specific kallikrein inhibitors. Agents Actions Suppl. 1987;22:381-90. PubMed PMID: 3481213.